become less frequent, whereas an increasing incidence of bacteraemia due to Gram-positive bacteria has been reported by several haematological and stem cell transplant centres. 1, 2 Although the majority of these infections are caused by coagulase-negative staphylococci, a large number are due to viridans streptococci. In contrast to what is seen in septicaemia due to coagulase-negative staphylococci, it has been described that 3-33% of cases of viridans streptococcal bacteraemia among neutropenic patients are associated with rapid onset of severe septic syndrome including shock and acute respiratory distress syndrome (ARDS). [3] [4] [5] Viridans streptococci are normally considered to be of low virulence even though they can occasionally cause infections such as subacute endocarditis and, some subgroups, in particular Streptococcus intermedius (milleri), even cause invasive pyogenic infections, including brain, pulmonary and abdominal abscesses, and osteomyelitis, in immunocompetent individuals. 6, 7 Relatively little is known about the immunopathogenesis of these diseases. A role for cell wall components of Streptococcus mitis in induction of shock through a TNFa-dependent pathway was suggested in an experimental murine model. 8 Previous studies have also shown that viridans streptococci isolated from neutropenic patients can induce proinflammatory cytokines, among others IL1b, IL8, and TNFb. 9, 10 This is of interest since IL8 production has been suggested to be associated with neutrophil accumulation and lung damage in patients with ARDS. 11, 12 In this study we investigated whether varying clinical manifestations of viridans streptococcal bacteraemia in neutropenic patients are related to differences between isolates in their capacity to induce proinflammatory responses.
Material and methods

Clinical isolates and patient characteristics
A retrospective screening of stem cell transplanted and leukaemic patients during the period 1995-2002 was performed in order to identify neutropenic patients with severe or nonsevere sepsis caused by viridans streptococci. Screening was only performed for the last 7 years since this is the current time limitation for storage of blood-culture isolates at the bacteriological laboratory at Huddinge University Hospital, Stockholm, Sweden. One case was included from Hospital for Sick Children, Toronto, Canada. The following definitions were utilized in the screening: neutropenia (ie profound neutropenia), neutrophils o0.1 Â 10 9 /l following either high-dose chemotherapy for acute myeloid leukaemia or stem cell transplantation; bacteraemia, growth of bacteria in at least one pair of blood culture-bottles taken in relation to a fever episode during neutropenia; severe sepsis, sepsis associated with shock and ARDS, or organ dysfunction, hypoperfusion, or hypotension; nonsevere sepsis, cases with bacteraemia only related to fever without shock, ARDS, or any organ dysfunction.
Nine patients were identified who, during profound neutropenia, had at least one episode of bacteraemia due to viridans streptococci and developed severe sepsis syndrome with or without ARDS. These strains were compared with 10 isolates from 10 nonsevere septic episodes in neutropenic patients. Cases 2 and 6 experienced two septic episodes, one severe and one nonsevere, caused by different viridans streptococcal strains. The patient characteristics are described in Table 1 .
In seven of the 19 septic episodes, patients received adequate empiric antibiotic therapy, three were treated with antibiotics that were not completely efficient against their infection, and nine patients had strains resistant against the empiric antibiotic therapy.
Bacterial typing
All 19 viridans streptococcal strains were typed based on the presence of glycoside hydrolases, phosphatases, esterases, and lipases determined using API ZYM (API System, La Balme-Les-Grottes, France). Production of the extracellular polysaccharide dextran was tested by ethanol precipitation. 13 Pulse-field gel electrophoresis (PFGE)
Isolates from cases 2 and 6 who experienced two septic episodes (one severe and one nonsevere) were further characterized by PFGE. The PFGE procedure was adapted from the procedure described by Hermans et al.
14 Chromosomal restriction fragments obtained by cleavage with restriction enzyme ApaI were embedded in agarose and separated on a 1% agarose gel by pulse-field electrophoresis performed for 22 h at 141C at 6 V/cm in 0.5 Â Trisborate-EDTA with pulse times of 2-30 s and an angle of 601. After electrophoresis, the gel was stained with ethidium bromide for 30 min (1 mg/ml).
Preparation of bacterial culture supernatant and heat-killed bacteria
The isolates were cultured overnight in 15 ml Todd-Hewitt broth (Difco, Detroit, MI, USA) supplemented with 1.5% yeast extract (Difco) at 371C. A b-haemolytic group-A streptococcal isolate of serotype T3/B3264 treated in the same manner as the viridans streptococcal isolates was used as a positive control at a dilution of 1:100. Cases had two bacteraemic episodes, one severe and one nonsevere, caused by different viridans streptococcal isolates.
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Both bacterial culture supernatant and heat-killed bacteria were prepared from each isolate. The bacteria and supernatant were separated by centrifugation, and proteins in the culture supernatants were precipitated by ethanol as previously described in detail. 15 The cell-free culture supernatants were stored at À201C until used. The bacterial pellet was resuspended in 1 ml PBS, boiled for 10 min and washed three times with phosphate-buffered saline (PBS), resuspended in 1 ml PBS, and stored at -201C until used.
Viable bacterial counts (CFU/ml) were determined for each isolate by serial dilution and plating on blood-agar plates. Dose-response experiments were performed to determine the optimal concentration of cell-free culture supernatants and heat-killed bacteria. A concentration of 6 Â 10 8 CFU/ml was found to be an optimal standard concentration for all strains and for both bacterial preparations.
Lipopolysaccharide (LPS) from E. coli 055:B5 provided by Division of Tumor Biology, Karolinska Institutet, was used at a concentration of 100 ng/ml.
Preparation of peripheral blood mononuclear cells (PBMC) and proliferation assay
PBMC were isolated from heparinized blood of healthy donors by Ficoll-Hypaque gradient centrifugation. The PBMC were cultured in RPMI 1640 medium supplemented with 25 mM HEPES, 4 mM L-glutamine, 100 U/ml penicillin/ streptomycin, and 5% heat-inactivated foetal calf serum (FCS). PBMC (1 Â 10 6 cells/ml) were stimulated with the optimal concentrations of sterile culture supernatants or heat-killed bacteria. After 72 h, the cells were pulsed for 6 h with 1 mCi per well of [ 3 H]thymidine (specific activity, 5.0 Ci/mmol; Amersham Pharmacia Biotech, UK). Phytohaemagglutinin-L (PHA) (Sigma, St Louis, MO, USA) was used as a positive control at a concentration of 1 mg/ml. All samples were assayed in triplicate. The experiments were repeated three times using cells from different individuals.
Cytokine analyses
Simultaneously with the proliferation assay, the cell cultures were tested for cytokine production. PBMC (1 Â 10 6 cells/ml), prepared and stimulated as previously described above, were harvested after 4 h of cultures for TNFa analysis, after 24 h for IL1b and IL8, and after 72 h for IL8, TNFb, and IFNg analysis. The stimulated cells and cell culture supernatants were separated by centrifugation, and the supernatants were stored at -201C. Cytokine production was assessed at the single cell level by intracellular immunohistochemical staining, as previously described in detail. 16 The following cytokine-specific mAbs were used at concentrations of 2 mg/ml: IL8 (NAP-1, mouse IgG1), IL1b (cocktail of 2.D.8 and 1437.96.85, mouse IgG, R&D, Immunokontact, UK), TNFa (Mab1 and Mab11, mouse IgG1, Pharmingen, San Diego, CA, USA), TNFb (LTX-22, mouse IgG1, Bender Medsystem, Vienna, Austria), and IFNg (cocktail of 1-DIK and 7-B6-1, mouse IgG1, MabTech, Stockholm, Sweden). Biotinylated secondary goat anti-mouse IgG1antibody (Caltag Lab., San Francisco, CA, USA) was used at a dilution of 1:300, and immunohistochemical staining was achieved by use of the avidin/peroxidase solution (Vectastain Elite-ABC-Peroxidase, Vector Laboratories, Burlingame, CA, USA) and diaminobenzidine (DAB) substrate for peroxidase (Vector Laboratories). Duplicate fields were stained for each cytokine. Cytokine production was assessed by direct microscopy, and 500-700 cells were counted per field.
The concentrations of IL1b and IL8 in cell culture supernatants were determined by Luminex cytokine multiplex analyses using the Fluorokine MAP kits (R&D, Minneapolis, MN, USA) and the Luminex 100 instrument (Luminex Corp., Austin, TX, USA).
Serum samples collected during the septic episode were available from seven patients, three samples from severe sepsis episodes and five from nonsevere sepsis episodes. The sera had been stored frozen at À201C until analysis. IL1b and IL8 levels were determined by automated chemoluminescence immunoassay (IMMULITE s , DPC, CA, USA). The lower limits of detection were 5 pg/ml for both assays. Sensitivity of the assays were 1.5 and 2.0 pg/ml, respectively.
Statistics
The Mann-Whitney U-test was used to analyse differences between the severe and nonsevere cohorts. Comparison of matched isolates was performed by the Wilcoxon matched pairs test. A P-value o0.05 was considered as significant.
Results
Cytokine induction profile of viridans streptococci resembles that of LPS
After 24 h of stimulation with cell-free bacterial supernatant or heat-killed bacteria from all 19 viridans streptococcal strains, production of IL1b and IL8 by human PBMC could be detected (Table 2 ). IL8 induction was seen also after 72 h of stimulation (data not shown). Both bacterial preparations induced cytokine production, but significantly higher levels of IL1b were demonstrated after stimulation with heat-killed bacteria as compared to supernatants (Po0.01) ( Table 2) . Surprisingly, none of the isolates induced TNFa production after 24 h of stimulation (data not shown). Since TNFa production had previously been demonstrated in cell culture supernatants following stimulation with viridans streptococci, 9 we assumed that we might have missed the production peak. Therefore, we analysed TNFa production in PBMC stimulated for 4 h with either cell-free bacterial supernatant or heat-killed bacteria, and found high frequencies of TNFa-producing cells, ranging from 1 to 7%, in cultures stimulated with heat-killed bacteria (Table 3 ). The noted frequencies were in the same range as the positive control LPS, which induced TNFa production in 3% of the cells (data not shown). A majority (90%) of the cell-free viridans supernatants induced production of TNFa, but at significantly lower frequencies than heatkilled bacteria (Po0.01) ( Table 3 ).
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Viridans streptococcal strains induced no or only very low production of TNFb or IFNg, whereas these cytokines were produced at high frequencies (3.5-5.5%) following stimulation with supernatant from a culture of b-haemolytic group A streptococci (data not shown). Similarly, bacterial supernatants and heat-killed bacteria from viridans streptococci did not induce a significant proliferative response, whereas culture supernatant from bhaemolytic streptococci group A showed high mitogenic activity (data not shown).
Cytokine-inducing activity of isolates that caused sepsis episodes of varying severity in the same patient
Comparison of the strains isolated from either severe sepsis episodes or nonsevere sepsis showed that there was no significant difference in cytokine-inducing capacity between the two groups (Tables 2 and 3 ). The material included two cases (2 and 6), who each experienced two episodes, one severe and one nonsevere, of bacteraemia caused by viridans streptococci, following chemotherapy including high-dose cytosine arabinoside ( Table 1 ). The severe episode in both cases included shock and ARDS, whereas only fever and elevated CRP but no signs of organ involvement was seen during the nonsevere episodes. The strains were typed both by biochemical typing and by PFGE to verify that the two episodes in each case were indeed caused by different strains. Matched comparisons of these strains causing infections of starkly varying severity in the same individual revealed that in both cases, the isolates causing severe sepsis induced significantly higher IL1b production as compared to the isolate causing the nonsevere sepsis (Po0.04) (Figure 1) . A similar trend was also noted for induction of IL8 (Figure 1 ). Cytokine producing cells (%) Figure 1 IL1b and IL8 production induced by viridans streptococcal strains that caused septic episodes of varying severity in the same patient. PBMC from healthy individuals were stimulated with bacterial culture supernatants prepared from the strains causing severe (filled symbols) or nonsevere sepsis (open symbol), respectively, in the same case: (a) case 2 and (b) case 6. Cells were harvested after 24 h of culture and stained for IL1b and IL8 cytokines by immunohistochemistry. The experiments were repeated six times using cells from different individuals. Statistically significant differences between isolates causing severe or nonsevere sepsis were determined by the Wilcoxon matched pairs test, and P-values are indicated in the figure.
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Higher IL8 levels in acute phase sera from patients with severe sepsis as compared to nonsevere Sera collected during the septic episode were available from seven of the patients, three severe and five nonsevere septic episodes, including case 2 who experienced two episodes, one severe and one nonsevere. These samples were analysed for IL1b and IL8 levels by ELISA. In agreement with a previous study, 17 IL1b could not be detected in serum from any of these patients. In contrast, IL8 could be detected in all serum samples, and the highest levels were consistently found in sera from severe episodes as compared to nonsevere (Figure 2 ). Sera were available from the two sepsis episodes of case 2, and markedly higher IL8 levels were found in serum collected during the severe episode as compared to the nonsevere, 4510 (day 4 after onset of sepsis) and 10 (day 2 after onset of sepsis) pg/ml, respectively ( Figure 2 ).
Discussion
Viridans streptococcal infection causes different clinical manifestations depending on the host's immune status. In immunocompetent individuals, infections are rare, but when they do occur they usually present with mild clinical symptoms even in bacteraemia and subacute endocarditis, although Streptococcus milleri can cause invasive pyogenic infections. 7 In contrast, in neutropenic patients, bacteraemia is frequently seen and septic shock syndrome including ARDS has been described. 3, 5, 18 No cases of viridans streptococcal septic shock syndrome in immunocompetent hosts have been reported, thus, suggesting that host factors must be crucial in the development of septic shock/ARDS. However, in the majority of neutropenic patients, viridans streptococcal bacteraemia resolves without further complications, indicating that bacterial factors may also be relevant. Furthermore, ARDS has not been described in relation to bacteraemia caused by other low-virulent Grampositive bacteria such as coagulase-negative staphylococci, which are at least as common as viridans streptococci in this patient setting. 19 To investigate whether bacterial factors are strong determinants of the severity of sepsis, we identified cohorts of patients who experienced either severe or nonsevere episodes of viridans streptococcal sepsis. The two cohorts were well matched with respect to clinical diagnosis, treatment, and prevalence of mucositis. The latter was found in approximately 50% of the cases in the respective cohort. As expected, the mortality rate was high in the severe cohort (56%), whereas all survived in the nonsevere cohort. The mortality was not related to strain sensitivity to the antibiotic therapy, since the mortality was 33 and 28% in patients receiving ineffective or adequate empiric antibiotic therapy, respectively. This is in agreement with previous studies reporting that the susceptibility of viridans streptococci against empirical antibiotic therapy does not correlate with better prognosis in this patient category. 1, 4, 18, 20, 21 We chose to test the isolates for induction of IL1b and TNFa since these cytokines' relation to severe sepsis and septic shock is well described:
22-24 IL8 due to its association with ARDS; 11, 12, 25 and TNFb and IFNg as markers for superantigen triggered T-cell activation. 26 In order to examine both cell wall components and potential exotoxin activity, we analysed the proinflammatory response induced by heat-killed bacteria as well as supernatants from overnight cultures containing extracellular proteins. The study showed that the strains, both heat-killed and bacterial supernatants, were potent inducers of proinflammatory cytokines. However, the most potent cytokine induction was consistently seen with heat-killed bacteria as compared to bacterial supernatant. The cytokine induction profile of viridans streptococcal strains strongly resembled that previously described for LPS, 16 with early TNFa production peaking at 4-6 h, potent IL1b and IL8 after 24 h of stimulation, and lack of or only very low induction of Tcell cytokines. It seems likely that the proinflammatory activity induced by heat-killed bacteria may be mediated by peptidoglycan and lipoteichoic acid, since they have been shown to induce proinflammatory cytokine production. [27] [28] [29] Also cell-free supernatants from overnight cultures of the isolates were potent proinflammatory inducers. The proinflammatory inducing molecules in the supernatants may be either shedded cell wall components and/or exotoxins. One report has described an extracellular product of S. mitis that caused selective activation of T cells expressing Vb2 and Vb5.1, and hence was suggested as a potential superantigen. 30 In this study, we could not find any evidence for secreted factors with superantigenic activity among the 19 tested isolates, since the supernatants did not have mitogenic activity nor did they induce the characteristic T-cell cytokines TNFb and IFNg. This is consistent with other reports of lack of mitogenic activity by viridans streptococcal culture supernatants. 9 Comparison of strains that caused either severe or nonsevere sepsis did not reveal a difference with respect to proinflammatory activity. However, the patient material contained two cases who had experienced two episodes of Severe Sepsis Non-Severe Sepsis † Figure 2 IL8 levels in sera from patients with viridans streptococal bacteraemia. Sera were available from seven cases, including three severe episodes and five nonsevere episodes, as indicated in the figure. The samples were analysed for IL8 levels by ELISA. The sera were collected on days 0-7 from onset of symptoms of infection where day 0 refers to the first day of fever and positive blood cultures. Sera from the severe cases were obtained on days 1, 7, and 4, and sera from nonsevere cases on days 1-4. w10 pg/ml (not shown in the figure).
sepsis, one severe and one nonsevere, and comparison of these matched isolates from the same patient revealed that the isolates causing the severe sepsis were more potent cytokine inducers than the isolates causing nonsevere sepsis. Furthermore, the finding that serum collected during the severe sepsis episode contained more than 400-fold IL8 levels than serum from the nonsevere sepsis episode further supported this noted difference between the strains. Most probably, the development of severe sepsis/ARDS due to viridans streptococcal bacteraemia in neutropenic patients is dependent on both host and bacterial factors, and most importantly the interplay between the host and the pathogen. Cell wall components as peptidoglycan and lipotheichoic acid have been shown to activate the innate immunity through activation of Toll-like receptors (TLR) in particular TLR 2, which subsequently induces expression of proinflammatory genes by triggering activation of NF-kB. [31] [32] [33] Thus, variations in expression of these receptors may explain interindividual variations in response to specific microbial infections. In addition, differences in characteristics of cell wall components or exotoxins can lead to variations in the activation of innate immune responses. Interactions between microbes and epithelial and endothelial cell surface receptors may also be important with regard to bacterial as well as hostdependent factors. 34 Further studies are required to understand fully the interplay between host and pathogen in viridans streptococcal sepsis and shock, and the results of this study indicate that success of such studies may require matched host and pathogen samples.
